News and Trends 31 Oct 2024 Halloween biotech stories: Unveiling scientists’ worst fears …gene-editing tools like CRISPR to do that work. These bioengineering techniques can manipulate DNA and genomes or the genetic material in an organism. That combined with recovered DNA makes de-extinction… October 31, 2024 - 15 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Best in Biotech 30 Sep 2025 CRISPR technology’s next wave: Ten companies to watch in 2025 …defense mechanism used by bacteria to protect against viral infections. The system uses a guide RNA to direct the Cas9 enzyme to a specific location in the genome, where it… September 30, 2025 - 15 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Inside Labiotech 15 Mar 2018 Why is Victor Dillard, Founder of Desktop Genetics, reading Labiotech.eu? Leaders & Readers: I had a chat with Victor Dillard about why he reads Labiotech.eu. He’s the COO/CFO, and Founder of Desktop Genetics, a leader in genome editing technology that… March 15, 2018 - 2 minutesmins - By Katherine Douglas Share WhatsApp Twitter Linkedin Email
Best in Biotech 8 May 2019 Top 10 Biotechs in Lausanne …diagnostics Sophia Genetics applies AI to the analysis of the human genome with the goal of making personalized treatment recommendations to patients with cancer or genetic diseases. The company has… May 8, 2019 - 7 minutesmins - By David Cox Share WhatsApp Twitter Linkedin Email
Opinion 11 Jul 2022 Precision medicine: the next big leap for metabolic disorders …part of our genome that codes our proteins. Which proteins actually get made in the cell, the modifications these proteins undergo and the influence of our metabolic processes all contribute… July 11, 2022 - 6 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 25 Feb 2017 Art Made with Human DNA Explores the Future of Genetics in Birmingham …piece was created in collaboration with professor and bioartist Simon Park. As part of the “100,000 Genomes Project“, it is intended to raise public awareness about research into the human… February 25, 2017 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
In Depth 19 Jan 2024 Re-coding the brain: Is CRISPR capable of curing neurodegenerative diseases? …a two- to three-fold higher risk of getting it, while two copies increase the risk eight- to twelvefold. In this study, researchers used an epigenome therapy platform based on the… January 19, 2024 - 9 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 12 Dec 2022 Studying the global spread of antimicrobial resistance …global challenge of AMR. By examining the whole genome sequences of around two thousand resistant bacteria, predominantly Escherichia coli, collected between 2008 and 2016, the team found that different types… December 12, 2022 - 4 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 19 Dec 2018 Could We Use CRISPR to Light up Future Christmas Trees? …to edit the genome. For this reason, it is now a standard tool in research and development centers worldwide, and companies such as the German chemical producer BASF are also… December 19, 2018 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 30 May 2023 Pancreatic cancer microbiome discovery holds treatment hope …proteins derived from bacteriophages. Securing genetic resources iNtRON has been conducting research mainly focused on lytic bacteriophages for securing IR candidates and obtaining open reading frames (ORFs) within its genomes…. May 30, 2023 - 4 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 5 May 2023 ‘Birth of a chromosome’ could boost cancer and infertility research …them to better cheat.” Importantly, meiotic drive is a powerful force that can shape how genomes evolve. These findings originating in the Hawley Lab and actively investigated by Hanlon, now… May 5, 2023 - 4 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 11 Oct 2022 Illumina and AstraZeneca look to drug target discovery with ‘pivotal research collaboration’ Illumina Inc. has announced a strategic research collaboration with AstraZeneca to accelerate drug target discovery by combining their work in artificial intelligence (AI) based genome interpretation and genomic analysis techniques… October 11, 2022 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email